ChitogenX Inc.
CHNXF · OTC
1/31/2024 | 1/31/2023 | 1/31/2022 | 1/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $42 | $59 | $69 | $89 |
| Gross Profit | -$42 | -$59 | -$69 | -$89 |
| % Margin | – | – | – | – |
| R&D Expenses | $1,071 | $2,359 | $1,734 | $1,197 |
| G&A Expenses | $1,340 | $2,474 | $1,708 | $1,774 |
| SG&A Expenses | $1,759 | $2,474 | $1,708 | $1,774 |
| Sales & Mktg Exp. | $419 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2,830 | $4,833 | $3,442 | $2,971 |
| Operating Income | -$2,830 | -$4,892 | -$3,511 | -$2,760 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,276 | -$1,338 | -$1,410 | -$1,012 |
| Pre-Tax Income | -$1,554 | -$6,230 | -$4,921 | -$3,772 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,554 | -$6,230 | -$4,921 | -$3,772 |
| % Margin | – | – | – | – |
| EPS | -0.021 | -0.13 | -0.14 | -0.13 |
| % Growth | 83.6% | 7.1% | -7.7% | – |
| EPS Diluted | -0.021 | -0.13 | -0.14 | -0.13 |
| Weighted Avg Shares Out | 73,002 | 48,262 | 34,897 | 28,749 |
| Weighted Avg Shares Out Dil | 73,000 | 48,262 | 34,897 | 28,749 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $842 | $1,406 | $1,190 | $836 |
| Depreciation & Amortization | $42 | $59 | $69 | $89 |
| EBITDA | -$2,694 | -$4,650 | -$3,188 | -$2,541 |
| % Margin | – | – | – | – |